IRON as of Oct 31 · 02:51 ET
IRONNasdaqPharmaceutical Preparations

Disc Medicine, Inc. · Brief

Next report

124 days

Mar 4 · before openest.Q4 FY26

Expected move

Inputs

Implied vs realized

8 reportsHistory
0 of 8≥ implied
avg implied
±8.6%
avg realized
±2.1%
Feb 27 '25±8.2%▲+0.07%×0.01
May 7 '25±9.0%▲+2.29%×0.25
Aug 7 '25±7.5%▼−3.27%×0.44
Nov 6 '25±9.2%▼−1.48%×0.16
Q1 FY26±9.0%▲+1.52%×0.17
May 5 '26±8.2%▼−0.07%×0.01
Q2 FY26±8.8%▲+7.52%×0.85
Oct 22 '26±8.5%▼−0.69%×0.08
quarterimplied−10%0+10%realized×
Oct '26±8.5%▼−0.69%×0.08
Q2 FY26±8.8%▲+7.52%×0.85
May '26±8.2%▼−0.07%×0.01
Q1 FY26±9.0%▲+1.52%×0.17
Nov '25±9.2%▼−1.48%×0.16
Aug '25±7.5%▼−3.27%×0.44
2 older reports
May '25±9.0%▲+2.29%×0.25
Feb '25±8.2%▲+0.07%×0.01
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Mar 4 report · est.

Bull2 of 3

4tracked funds reporting a holding in the companyN-PORT · Aug 31 '26
221managers reporting a position in the latest quarter13F · Jun 30 '26

Bear2 of 3

8 of 8recent reports with moves below the options implied rangeEarnings history
7 of 25largest reporting managers reducing their stake in the latest quarter13F · Jun 30 '26
AI captions · Oct 26 '26once per report · top 2 per case

Linked exposure

IRON report session

No linked exposure.

Latest changes

30 daysAll changes
Oct 22impliedImplied move: ±8.5% into Oct 22 earnings (Oct 22 close).Source
Oct 228-KMaterial agreement: Underwriting Agreement with Jefferies LLC, Leerink Partners LLC, Morgan Stanley & Co. LLC and Cantor Fitzgerald &…Source
Oct 19haltTrading halt: 06:55 ET, resumed 07:20 ET.Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.